The Offering Clause Example with 4 Variations from Business Contracts

This page contains The Offering clauses in business contracts and legal agreements. An example clause is provided at the top of the page, followed by clauses with minor variations. You can view the text differences by selecting the "Show Differences" option.
The Offering. This subscription is submitted to you in accordance with and subject to the terms and conditions described in this Subscription Agreement and the Confidential Private Placement Memorandum of the Company dated December 1, 2016, as amended or supplemented from time to time, including all attachments, schedules and exhibits thereto (the "Memorandum"), relating to the offering (the "Offering") by the Company of a minimum of 4,000,000 Units ($20,000,000) ("Minimum Offering Amount"), and up to a maxim...um of 5,000,000 Units ($25,000,000) ("Maximum Offering Amount"). In the event the Maximum Offering Amount is sold, the Placement Agent (as defined below) and the Company shall have the right to sell up to an additional 1,000,000 Units ($5,000,000) to cover over-allotments. Aegis Capital Corp. has been engaged as exclusive placement agent in connection with the Offering ("Aegis" or the "Placement Agent"). The terms of the Offering are more completely described in the Memorandum and such terms are incorporated herein in their entirety. View More
Found in Motus GI Holdings, Inc. contract

Variations of a "The Offering" Clause from Business Contracts

The Offering. This subscription is submitted to you in accordance with and subject to the terms and conditions described in this Subscription Agreement and the Confidential Private Placement Memorandum of the Company dated December 1, 2016, agreement, as amended or supplemented from time to time, including all attachments, schedules and exhibits thereto (the "Memorandum"), (collectively, the "Subscription Agreement"), relating to the offering (the "Offering") by the Company of a minimum of 4,000,000 Units ($2...0,000,000) ("Minimum Offering Amount"), and up to a maximum of 5,000,000 200,000 Units ($25,000,000) ($1,000,000) ("Maximum Offering Amount"). In the event the Maximum Offering Amount is sold, the Placement Agent (as defined below) and the Company shall have the right to sell up to an additional 1,000,000 200,000 Units ($5,000,000) ($1,000,000) to cover over-allotments. Aegis Capital Corp. has been engaged by the Company as exclusive placement agent in connection with the Offering ("Aegis" or the "Placement Agent"). The terms of the Offering are more completely described in the Memorandum and such terms are incorporated herein in their entirety. View More
Found in Adgero Biopharmaceuticals Holdings, Inc. contract
The Offering. This subscription is submitted to you in accordance with and subject to the terms and conditions described in this Subscription Agreement and the Confidential Private Placement Memorandum of the Company dated December 1, 2016, July 11, 2013, as amended or supplemented from time to time, including all attachments, schedules and exhibits thereto (the "Memorandum"), relating to the offering (the "Offering") by the Company of a minimum of 4,000,000 24 Units ($20,000,000) ($6,000,000) ("Minimum Offer...ing Amount"), and up to a maximum of 5,000,000 36 Units ($25,000,000) ($9,000,000) ("Maximum Offering Amount"). In the event the Maximum Offering Amount is sold, the Placement Agent (as defined below) and the Company shall have the right to sell up to place an additional 1,000,000 24 Units ($5,000,000) ($6,000,000) to cover over-allotments. Aegis Capital Corp. has been engaged as exclusive placement agent in connection with the Offering ("Aegis" or the (the "Placement Agent"). The terms of the Offering are more completely described in the Memorandum and such terms are incorporated herein in their entirety. View More
Found in Matinas BioPharma Holdings, Inc. contract
The Offering. This subscription is submitted to you in accordance with and subject to the terms and conditions described in this Subscription Agreement and the Confidential Private Placement Memorandum of the Company dated December 1, 2016, March 27, 2014, as amended or supplemented from time to time, including all attachments, schedules and exhibits thereto (the "Memorandum"), relating to the offering (the "Offering") by the Company of a minimum of 4,000,000 18 Units ($20,000,000) ($4,500,000) ("Minimum Offe...ring Amount"), and up to a maximum of 5,000,000 36 Units ($25,000,000) ($9,000,000) ("Maximum Offering Amount"). In the event the Maximum Offering Amount is sold, the Placement Agent (as defined below) and the Company shall have the right to sell up to place an additional 1,000,000 16 Units ($5,000,000) ($4,000,000) to cover over-allotments. Aegis Capital Corp. has been engaged as exclusive placement agent in connection with the Offering ("Aegis" or the (the "Placement Agent"). The terms of the Offering are more completely described in the Memorandum and such terms are incorporated herein in their entirety. View More
Found in Corbus Pharmaceuticals Holdings, Inc. contract
The Offering. This subscription is submitted to you in accordance with and subject to the terms and conditions described in this Subscription Agreement and the Confidential Private Placement Memorandum of the Company dated December 1, January 11, 2016, as amended or supplemented from time to time, including all attachments, schedules and exhibits thereto (the "Memorandum"), relating to the offering (the "Offering") by the Company of a minimum of 4,000,000 600,000 Units ($20,000,000) ($3,000,000) ("Minimum Off...ering Amount"), and up to a maximum of 5,000,000 1,500,000 Units ($25,000,000) ($7,500,000) ("Maximum Offering Amount"). In the event the Maximum Offering Amount is sold, the Placement Agent (as defined below) and the Company shall have the right to sell up to an additional 1,000,000 1,500,000 Units ($5,000,000) ($7,500,000) to cover over-allotments. Aegis Capital Corp. has been engaged as exclusive placement agent in connection with the Offering ("Aegis" or the "Placement Agent"). The terms of the Offering are more completely described in the Memorandum and such terms are incorporated herein in their entirety. View More
Found in Adgero Biopharmaceuticals Holdings, Inc. contract